Just in the past years, scientists have actually realized the huge role that the microbes living inside and on us play in our health. The human microbiome, and particularly the gut microbiome, has actually been linked to multiple persistent diseases, consisting of diabetes. An unbalanced microbiome composition has been found in clients with diabetes, who tend to have a less diverse gut microbiome as compared to healthy individuals. Feature.
Some companies are developing diabetes treatments targeting the microbiome. The French Valviotis is presently conducting preclinical testing of a drug aimed at increasing the microbiome variety as a treatment for type 2 diabetes. Although promising, the microbiome field is extremely young and its complexity makes it tough to develop causation after finding correlation.
That world may not be so far away, as many companies are establishing non-invasive approaches to replace finger pricking. Feature. Stability Applications has established a gadget called GlucoTrack that can measure glucose using electromagnetic waves and is already readily available in Europe. Similar technologies are appearing, with GlucoSense in London utilizing laser light to measure sugar levels and MediWise using radio waves.
The GlucoWise sensing unit prototypePatches are also becoming a popular kind of measuring blood glucose without needles, such as FreeStyle Libre, an inch-wide spot that can be used for as much as 2 weeks. At the University of Bath, researchers are developing a graphene spot that might provide greater precision by measuring sugar levels individually in multiple hair follicles – Feature.
On the other hand, Senseonic and Roche are working on a gadget that is implanted under the skin. Feature. Still, non-invasive alternatives to measure blood sugar frequently face concerns regarding accuracy. The famous glucose-measuring contact lens that Google announced in 2014 was dismissed as “technically infeasible” and even more advancements will be required to reach the degree of accuracy of finger-pricking approaches.
Researchers are already hypothesizing about microchips that can detect diabetes type 1 before the signs appear or nanorobots taking a trip in the bloodstream while they measure glucose and provide insulin – Feature.”There’s little fiction left in this. I highly believe that microrobotics will come and will belong to our drug shipment within the next ten years,” said Tomas Landh, Director of Method and Development Sourcing at Novo Nordisk, at the 2013 Medicon Valley Alliance Yearly MeetingWhatever the future brings, it will undoubtedly make a huge distinction in the lives of millions of individuals worldwide.